Oxford Biomedica Plc Stock Price Prediction
| OXBDF Stock | USD 2.62 0.01 0.38% |
Oversold Vs Overbought
51
Oversold | Overbought |
Oxford Biomedica plc stock price prediction is an act of determining the future value of Oxford Biomedica shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Oxford Biomedica's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Oxford Biomedica and does not consider all of the tangible or intangible factors available from Oxford Biomedica's fundamental data. We analyze noise-free headlines and recent hype associated with Oxford Biomedica plc, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether pink sheet price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Oxford Biomedica based on different types of headlines from major news networks to social media. The Oxford stock price prediction module provides an analysis of price elasticity to changes in media outlook on Oxford Biomedica over a specific investment horizon. Using Oxford Biomedica hype-based prediction, you can estimate the value of Oxford Biomedica plc from the perspective of Oxford Biomedica response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Oxford Biomedica. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Oxford Biomedica to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Oxford because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Oxford Biomedica after-hype prediction price | USD 2.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Oxford |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oxford Biomedica's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oxford Biomedica After-Hype Price Prediction Density Analysis
As far as predicting the price of Oxford Biomedica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oxford Biomedica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Oxford Biomedica, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Oxford Biomedica Estimiated After-Hype Price Volatility
In the context of predicting Oxford Biomedica's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oxford Biomedica's historical news coverage. Oxford Biomedica's after-hype downside and upside margins for the prediction period are 0.13 and 5.65, respectively. We have considered Oxford Biomedica's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Oxford Biomedica is risky at this time. Analysis and calculation of next after-hype price of Oxford Biomedica plc is based on 3 months time horizon.
Oxford Biomedica Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Oxford Biomedica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oxford Biomedica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oxford Biomedica, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.22 | 3.03 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.62 | 2.62 | 0.00 |
|
Oxford Biomedica Hype Timeline
Oxford Biomedica plc is now traded for 2.62. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Oxford is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.22%. %. The volatility of related hype on Oxford Biomedica is about 0.0%, with the expected price after the next announcement by competition of 2.62. About 63.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oxford Biomedica plc had not issued any dividends in recent years. The entity had 1:50 split on the 30th of May 2018. Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Oxford Biomedica Basic Forecasting Models to cross-verify your projections.Oxford Biomedica Related Hype Analysis
Having access to credible news sources related to Oxford Biomedica's direct competition is more important than ever and may enhance your ability to predict Oxford Biomedica's future price movements. Getting to know how Oxford Biomedica's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oxford Biomedica may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CVALF | Covalon Technologies | 0.00 | 0 per month | 0.00 | (0.02) | 4.71 | (5.88) | 20.37 | |
| BIOAF | biOasis Technologies | 0.00 | 0 per month | 10.79 | 0.11 | 40.00 | (25.00) | 100.00 | |
| CRPOF | Ceapro Inc | 0.00 | 0 per month | 0.00 | 0.09 | 6.25 | (5.88) | 39.22 | |
| RVXCF | Resverlogix Corp | 0.00 | 0 per month | 0.00 | (0.03) | 0.00 | 0.00 | 45.00 | |
| APTCF | Advanced Proteome Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CHNXF | ChitogenX | 0.00 | 0 per month | 0.00 | (0.09) | 9.84 | (11.50) | 30.17 |
Oxford Biomedica Additional Predictive Modules
Most predictive techniques to examine Oxford price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oxford using various technical indicators. When you analyze Oxford charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Oxford Biomedica Predictive Indicators
The successful prediction of Oxford Biomedica stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Oxford Biomedica plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Oxford Biomedica based on analysis of Oxford Biomedica hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Oxford Biomedica's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oxford Biomedica's related companies. Story Coverage note for Oxford Biomedica
The number of cover stories for Oxford Biomedica depends on current market conditions and Oxford Biomedica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oxford Biomedica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oxford Biomedica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Oxford Biomedica Short Properties
Oxford Biomedica's future price predictability will typically decrease when Oxford Biomedica's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oxford Biomedica plc often depends not only on the future outlook of the potential Oxford Biomedica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oxford Biomedica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 86.2 M |
Check out Oxford Biomedica Basic Forecasting Models to cross-verify your projections. Note that the Oxford Biomedica plc information on this page should be used as a complementary analysis to other Oxford Biomedica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Oxford Pink Sheet analysis
When running Oxford Biomedica's price analysis, check to measure Oxford Biomedica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxford Biomedica is operating at the current time. Most of Oxford Biomedica's value examination focuses on studying past and present price action to predict the probability of Oxford Biomedica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxford Biomedica's price. Additionally, you may evaluate how the addition of Oxford Biomedica to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |